Welcome to the Department of Radiation Oncology
Message from James M. Metz, MD — Chairman
Penn Radiation Oncology is dedicated to a three-part mission of excellence in patient care, basic and translational research, and the education of residents and students. We are committed to delivering excellence in every area and as such we steadfastly believe that "Excellence is Standard."
Penn Radiation Oncology is one of the most comprehensive radiation oncology programs in the world. The outstanding faculty and staff, combined with Penn’s extensive collection of advanced technology, gives patients access to nearly every treatment option available for their cancer. The broad range of radiation treatments available include Proton Therapy, intensity-modulated radiation therapy (IMRT), high-dose rate (HDR) and low-dose rate brachytherapy, partial breast irradiation, stereotactic radiosurgery (SRS), and Gamma Knife radiation. With the Abramson Cancer Center of the University of Pennsylvania, Penn Radiation Oncology provides patient care at the Ruth and Raymond Perelman Center for Advanced Medicine (PCAM), six major hospitals, and nine community-based sites.
Read more of the Message from the Chair »
Dr. Vapiwala named Eli Glatstein Professor »
News
-
Seven Penn, Children’s Hospital of Philadelphia faculty elected to American Society for Clinical Investigation
Monday, February 3, 2025
Yi Fan, MD, PhD, professor of Radiation Oncology, has been elected to the American Society of Clinical Investigation, joining one of the nation’s oldest and most respected medical honor societies composed of more than 3,000 physician-scientists representing all medical specialties. His research focuses on understanding how the body regulates blood vessel growth and immune responses, particularly in tumors and damaged tissues. Read More
-
The Ultra-fast Cancer Treatments Which Could Replace Conventional Radiotherapy
Wednesday, January 22, 2025
Researchers at Penn Medicine are part of a leading group of scientists and physicians across the world who are exploring the potential of FLASH, an ultra-high dose form of radiation therapy delivered in less than a second, to treat a wide range of cancer types. Alexander Lin, MD, the Morton M. Kligerman Professor of Radiation Oncology, and Constantinos Koumenis, PhD, the Richard H. Chamberlain Professor of Radiation Oncology, are working to launch a clinical trial at Penn Medicine using FLASH to treat recurrent head and neck cancer, to find out if the advanced therapy is able to successfully kill tumors, with fewer side effects than conventional radiation therapy.
-
ASTRO Members Receive Fellows Designation
Tuesday, August 13, 2024
American Society for Radiation Oncology (ASTRO) has selected 48 members to receive ASTRO fellow designation during the 2024 ASTRO Annual Meeting, including Dimitris N. Mihailidis, PhD, an associate professor of Clinical Radiation Oncology, and Ying Xiao, PhD, a professor of Radiation Oncology.